全文获取类型
收费全文 | 1382篇 |
免费 | 87篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 25篇 |
妇产科学 | 26篇 |
基础医学 | 201篇 |
口腔科学 | 4篇 |
临床医学 | 80篇 |
内科学 | 278篇 |
皮肤病学 | 32篇 |
神经病学 | 116篇 |
特种医学 | 41篇 |
外科学 | 119篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 90篇 |
眼科学 | 62篇 |
药学 | 140篇 |
中国医学 | 2篇 |
肿瘤学 | 240篇 |
出版年
2023年 | 6篇 |
2022年 | 8篇 |
2021年 | 25篇 |
2020年 | 18篇 |
2019年 | 29篇 |
2018年 | 32篇 |
2017年 | 20篇 |
2016年 | 26篇 |
2015年 | 29篇 |
2014年 | 37篇 |
2013年 | 60篇 |
2012年 | 89篇 |
2011年 | 86篇 |
2010年 | 53篇 |
2009年 | 51篇 |
2008年 | 98篇 |
2007年 | 71篇 |
2006年 | 85篇 |
2005年 | 74篇 |
2004年 | 79篇 |
2003年 | 58篇 |
2002年 | 54篇 |
2001年 | 32篇 |
2000年 | 31篇 |
1999年 | 31篇 |
1998年 | 15篇 |
1997年 | 11篇 |
1996年 | 9篇 |
1995年 | 10篇 |
1994年 | 6篇 |
1992年 | 27篇 |
1991年 | 25篇 |
1990年 | 24篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 14篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1984年 | 6篇 |
1983年 | 12篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 10篇 |
1978年 | 5篇 |
1975年 | 4篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1970年 | 5篇 |
1969年 | 5篇 |
1927年 | 4篇 |
排序方式: 共有1471条查询结果,搜索用时 140 毫秒
1.
2.
Zaher H. Sbeity Axel Jaksche Sybille Martin Karin U. Loeffler 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2006,244(7):883-884
Purpose We report a case of periocular subcutaneous macrofilariasis as an initial sign of a systemic Loa loa infection.Methods Thorough history, eye examination and surgical intervention. Parasitological and serological analysis.Results A periocular adult Loa loa worm was extracted from the left upper eyelid in an African student living in Germany after presenting to our department with intermittent attacks of painful lid swelling. Four weeks later he presented with Calabar swellings in his arms without serological evidence of microfilaria and was treated with diethylcarbamazine.Conclusion Due to increasing migration of populations to Europe rare manifestations of ocular loiasis are becoming more common. Intermittent painful eyelid swelling in patients who visited or have lived in Africa should always raise the suspicion of systemic loiasis. 相似文献
3.
Anna Gliszczyńska-Swig?o Hester van der Woude Laura de Haan Bozena Tyrakowska Jac M M J G Aarts Ivonne M C M Rietjens 《Toxicology in vitro》2003,17(4):423-431
The effects of quercetin on viability and proliferation of Chinese Hamster Ovary (CHO) cells and CHO cells overexpressing human quinone reductase (CHO+NQO1) were studied to investigate the involvement of the pro-oxidant quinone chemistry of quercetin. The toxicity of menadione was significantly reduced in CHO+NQO1 cells compared to wild-type CHO cells, validating the NQO1-overexpression in the CHO+NQO1 transfectant. Quercetin inhibited the proliferation of wild-type CHO and CHO+NQO1 cells to a similar extent without affecting cell viability, indicating that NQO1 enrichment of CHO cells did not provide increased protection. On the other hand, inhibition of NQO1 in both types of cells by dicoumarol significantly potentiated the inhibitory effect of quercetin on cell proliferation, revealing the role of NQO1 in cellular protection against quercetin. Altogether, these results can be explained by the hypothesis that both wild-type CHO and CHO+NQO1 cells contain sufficient NQO1 activity for optimal protection against the pro-oxidant effect of quercetin on cell proliferation. The results also point at a cellular NQO1 threshold for optimal protection against quercetin. This NQO1 threshold seems to be in the range of NQO1 activities already present in various tissues. 相似文献
4.
Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system 总被引:5,自引:0,他引:5 下载免费PDF全文
Loeffler J Schmidt K Hebart H Schumacher U Einsele H 《Journal of clinical microbiology》2002,40(6):2240-2243
A fully automated assay was established for the extraction of DNA from clinically important fungi by using the MagNA Pure LC instrument. The test was evaluated by DNA isolation from 23 species of yeast and filamentous fungi and by extractions (n = 28) of serially diluted Aspergillus fumigatus conidia (10(5) to 0 CFU/ml). Additionally, DNA from 67 clinical specimens was extracted and compared to the manual protocol. The detection limit of the MagNA Pure LC assay of 10 CFU corresponded to the sensitivity when DNA was extracted manually; in 9 of 28 runs, we could achieve a higher sensitivity of 1 CFU/ml blood, which was found to be significant (p 相似文献
5.
Evaluation of Murex CMV DNA Hybrid Capture Assay for Detection and Quantitation of Cytomegalovirus Infection in Patients following Allogeneic Stem Cell Transplantation 下载免费PDF全文
Holger Hebart Daphne Gamer Juergen Loeffler Claudia Mueller Christian Sinzger Gerhard Jahn Peter Bader Thomas Klingebiel Lothar Kanz Hermann Einsele 《Journal of clinical microbiology》1998,36(5):1333-1337
Murex hybrid capture DNA assay (HCS) is a solution hybridization antibody capture assay for detection and quantitation of cytomegalovirus (CMV) DNA in leukocytes. To determine whether CMV HCS is sensitive enough to initiate and monitor antiviral therapy after allogeneic stem cell transplantation (SCT), 51 consecutive SCT recipients were prospectively screened for the appearance of CMV infection by HCS, PCR, and culture assays from blood samples. Preemptive antiviral therapy was initiated after the second positive PCR result in all patients, as previously reported, and HCS was not considered for clinical decision making. A total of 417 samples were analyzed. Of these, 21 samples were found to be positive by PCR and HCS, 88 samples were PCR positive but HCS negative, and 308 were negative by both assays. Concordance of results between PCR and HCS and between HCS and blood culture was observed in 78.9 and 95.9% of the samples assayed, respectively. PCR was found to be more sensitive than HCS, and HCS was more sensitive than the blood culture assay (P < 0.0001). Four patients with symptomatic CMV infection were PCR positive prior to the onset of CMV-related symptoms, whereas HCS detected CMV DNA in three patients prior to and one at onset of CMV disease. The numbers of genomes per milliliter of blood were higher in patients with symptomatic CMV infection than in those with asymptomatic CMV infection (P = 0.06). None of the HCS-negative patients developed CMV disease. Thus, all patients with CMV disease were correctly identified by HCS; however, the lower sensitivity limit of the HCS assay may still be insufficient to allow diagnosis of CMV infection early enough to prevent CMV disease in patients following allogeneic SCT. 相似文献
6.
7.
Franco Laccone Ivonne Jünemann Sharon Whatley Rhian Morgan Rachel Butler Peter Huppke David Ravine 《Human mutation》2004,23(4):395-395
The original article to which this Erratum refers was published in Human Mutation 23:234–244 Human Mutation(2004) 23(3) 234–244 相似文献
8.
9.
Hans A. C. Alkemade Ivonne M. J. J. van Vlijmen-Willems Urbaan J. G. M. van Haelst Peter C. M. van de Kerkhof Joost Schalkwijk 《The Journal of pathology》1994,174(2):121-129
Skin-derived antileukoproteinase (SKALP), also known as elafin, is a strong and specific inhibitor of elastase and proteinase 3. SKALP is not present in normal epidermis, but is expressed by epidermal keratinocytes under hyperproliferative conditions such as psoriasis, wound healing, and in cell culture. In human epidermal tumours, SKALP is differentially expressed and restricted to tumours with distinct squamous differentiation. We have studied the presence of both SKALP and one of its known target enzymes, leukocyte elastase, in 41 squamous cell carcinomas of the skin. SKALP expression correlated with the degree of differentiation: strong expression was seen in well-differentiated cells and expression was absent in poorly differentiated tumour cells. Most of the squamous cell carcinomas showed elastase-positive cells in the tumour stroma and also within the tumour cell nests. SKALP may interfere with the proteoloytic activity of infiltrating inflammatory cells or with hitherto unknown proteinases from the tumour cells. We hypothesize that in squamous cell carcinoma progressive loss of SKALP expression could facilitate tumour spread. 相似文献
10.
BackgroundThe 30-day all-cause readmission rate is a widely used metric of hospital performance. However, there is lack of clarity as to whether 30 days is an appropriate time frame following surgical procedures. Our aim is to determine whether a 90-day time window is superior to a 30-day time window in capturing surgically relevant readmissions after total hip arthroplasty (THA) and total knee arthroplasty (TKA).MethodsWe analyzed readmissions following all primary THAs and TKAs recorded in the English National Health Service Hospital Episode Statistics database from 2008 to 2018. We compared temporal patterns of 30- and 90-day readmission rates for the following types of readmission: all-cause, surgical, return to theater, and those related to specific surgical complications.ResultsA total of 1.47 million procedures were recorded. After THA and TKA, over three-quarters of 90-day surgical readmissions took place within the first 30 days (78.5% and 75.7%, respectively). All-cause and surgical readmissions both peaked at day 4 and followed a similar temporal course thereafter. The ratio of surgical to medical readmissions was greater for THA than for TKA, with THA dislocation both being one of the most common surgical complications and clustering early after discharge, with 73.5% of 90-day dislocations occurring within the first 30 days.ConclusionThe 30-day all-cause readmission rate is a good reflection of surgically relevant readmissions that take place in the first 90 days after THA and TKA. 相似文献